透明质酸市场规模、份额、趋势分析报告：按应用、地区、细分市场预测，2024-2030

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2023年12月19日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

透明质酸市场成长与趋势：

根据Grand View Research, Inc.最新报告显示，预计2030年全球透明质酸市场规模将达167.5亿美元，2024年至2030年复合年增长率为7.7%。

大众对化学品的兴趣增加、渴望获得快速、明显的结果以及更快的恢復时间等因素是影响深远的渲染驱动因素。由于已开发国家和发展中国家越来越多地采用美容手术，该行业正在迅速发展。为了改善贴合度，透明质酸表面在心血管植入（如支架和血管移植物）中的使用越来越多，再加上抗老化产品的认识不断增强，这正在推动增长。

基于透明质酸的真皮填充剂的有效性和明显效果吸引了这一人群。此外，COVID-19大流行改变了许多行业的动态，旅行限制、社交距离和修改做法成为「新常态」。随着化妆品行业逐渐重新开放，许多医生报告说，有关整容手术的询问大幅增加。此外，国家隔离导致专业人士使用视讯会议设备，人们对自己的外表变得更加在意。在某些情况下，人们会选择美容治疗，这被称为「变焦热潮」或「变焦效应」。

受疫情影响，世界各地的整形外科医生的患者数量大幅增加，尤其是在美国、澳洲和日本等国家。 2022 年，北美地区占据最大的销售份额。儘管价格高，但对短期治疗方法的偏好以及骨关节炎等目标疾病的流行是导致高市占率的主要因素。 2022 年，北美地区最受欢迎的产品应用是型态治疗骨关节炎的真皮填充剂和黏胶补充品。预计亚太地区在预测期内复合年增长率最快。

中国和日本的老年人口不断增长，成为抗老化产品和服务的庞大基本客群。对产品用途和功效的认识不断提高也推动了需求。此外，可支配收入水准的上升进一步支持了该地区的扩张。过去两年，欧洲发生了显着变化。不断扩大的需求正在加剧新参与企业的价格竞争。世界卫生组织最近宣布英国和德国肥胖流行。人口高龄化与肥胖之间的关係是欧洲区域部门的潜在驱动力。

透明质酸市场报告亮点

骨关节炎领域在全球产业中占据主导地位，并在 2023 年占总收益的最大份额。
肥胖引起的骨关节炎和关节疼痛的增加增加了注射透明质酸作为治疗方法的需求。
透明质酸可作为减震器和缓衝垫，润滑关节并帮助它们正常运作。
有许多眼科手术产品含有透明质酸/透明质酸作为活性成分。
其中包括 Vitrax、Healon、Amvisco Plus、Amvisc、Hylan G-F20 和 Opegan。
与老龄化相关的眼科疾病、干眼症候群、成人视力障碍和糖尿病等慢性疾病的盛行率不断上升，是引导该细分市场成长的主要因素。

2023 年及 2030 年区域市场占有率分析
区域市场仪表板
全球区域市场概况
2018-2030年市场规模及预测趋势分析：
北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 挪威
- 瑞典
- 丹麦
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 泰国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东/非洲
- 南非
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 科威特

第六章竞争形势

主要市场参与企业的最新趋势和影响分析
公司/竞争分类
供应商形势
- 主要经销商及通路伙伴名单
- 主要客户
- 2023 年主要企业股票分析
- Allergan
- Sanofi
- Genzyme Corporation
- Anika Therapeutics, Inc.
- Salix Pharmaceuticals
- Seikagaku Corporation
- F. Hoffmann-La Roche Ag
- Galderma Laboratories LP
- Zimmer Biomet
- Smith &Nephew Plc
- Ferring BV
- Lifecore Biomedical, LLC
- HTL Biotechnology
- Shiseido Company, Limited
- Bloomage Biotechnology Corporation Limited
- LG Life Sciences Ltd（LG Chem.）
- Maruha Nichiro, Inc.

简介目录图表

Product Code: 978-1-68038-333-1

Hyaluronic Acid Market Growth & Trends:

The global hyaluronic acid market size is expected to reach USD 16.75 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers. The industry is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving compatibility coupled with the growing awareness about anti-aging products is fueling the growth.

The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base. Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the "new normal." As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious of their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed the "Zoom Boom" or the "Zoom effect."

Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia, and Japan. North America held the maximum revenue share in 2022. Preference for short-treatment regimens, even though high-priced, and the prevalence of target diseases, such as osteoarthritis, are the key factors attributed to the high share. In 2022, the most lucrative product applications in the North America region were in the form of dermal fillers and viscos supplements for the management of osteoarthritis. Asia Pacific is anticipated to register the fastest CAGR during the forecast period.

The growing geriatric population in China and Japan provide a large customer base for anti-aging products and services. Rising awareness about product applications and efficacy also fuels the demand. In addition, increasing disposable income levels are further supporting the region's expansion. Europe has undergone impressive changes over the last 2 years. The growing demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany. The relationship between the increasing aging population and obesity is a potential driver for the Europe regional sector

Hyaluronic Acid Market Report Highlights:

The osteoarthritis segment dominated the global industry and accounted for the maximum share of the overall revenue in 2023
The rising obesity resulting in osteoarthritis and joint pain has increased the demand for hyaluronic acid injections as a treatment
Hyaluronic acid acts as a shock absorber or a cushion and lubricates the joints, thus helping in proper functioning
There are a number of ophthalmic surgical products that use hyaluronan/hyaluronic acid as an active ingredient
These include Vitrax, Healon, Amivisc Plus, Amvisc, Hylan G-F20, and Opegan
The increasing prevalence of age-related eye diseases, dry eye syndrome, adult-vision impairments, and chronic diseases, such as diabetes, are major factors leading to segment growth.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Application
- 1.2.2. Regional scope
- 1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Application
- 2.2.2. Regional outlook
2.3. Competitive Insights

Chapter 3. Hyaluronic Acid Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing Geriatric Population
  - 3.2.1.2. Growing Awareness for Antiaging Products
  - 3.2.1.3. High Prevalence of Target Diseases
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Associated adverse effects of hyaluronic acid
  - 3.2.2.2. High cost of products and related services
3.3. Hyaluronic Acid Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Hyaluronic Acid Market: Application Estimates & Trend Analysis

4.1. Application Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Hyaluronic Acid Market by Application Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
- 4.4.1. Dermal fillers
  - 4.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 4.4.2. Osteoarthritis
  - 4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 4.4.2.2. Single-injection
  - 4.4.2.2.1 Market estimates and forecasts 2018 - 2030 (USD Million)
  - 4.4.2.3. Three-injection
  - 4.4.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  - 4.4.2.3. Five-injection
  - 4.4.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
- 4.4.3. Ophthalmic
  - 4.4.3.3. Market estimates and forecasts 2018 - 2030 (USD Million)
- 4.4.4. Vesicoureteral reflux
  - 4.4.2.3. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis

5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
5.5. North America
- 5.5.1. U.S.
  - 5.5.1.1. Key country dynamics
  - 5.5.1.2. Regulatory framework/ reimbursement structure
  - 5.5.1.3. Competitive scenario
  - 5.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
- 5.5.2. Canada
  - 5.5.2.1. Key country dynamics
  - 5.5.2.2. Regulatory framework/ reimbursement structure
  - 5.5.2.3. Competitive scenario
  - 5.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Europe
- 5.6.1. UK
  - 5.6.1.1. Key country dynamics
  - 5.6.1.2. Regulatory framework/ reimbursement structure
  - 5.6.1.3. Competitive scenario
  - 5.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6.2. Germany
  - 5.6.2.1. Key country dynamics
  - 5.6.2.2. Regulatory framework/ reimbursement structure
  - 5.6.2.3. Competitive scenario
  - 5.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6.3. France
  - 5.6.3.1. Key country dynamics
  - 5.6.3.2. Regulatory framework/ reimbursement structure
  - 5.6.3.3. Competitive scenario
  - 5.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6.4. Italy
  - 5.6.4.1. Key country dynamics
  - 5.6.4.2. Regulatory framework/ reimbursement structure
  - 5.6.4.3. Competitive scenario
  - 5.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6.5. Spain
  - 5.6.5.1. Key country dynamics
  - 5.6.5.2. Regulatory framework/ reimbursement structure
  - 5.6.5.3. Competitive scenario
  - 5.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6.6. Norway
  - 5.6.6.1. Key country dynamics
  - 5.6.6.2. Regulatory framework/ reimbursement structure
  - 5.6.6.3. Competitive scenario
  - 5.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6.7. Sweden
  - 5.6.7.1. Key country dynamics
  - 5.6.7.2. Regulatory framework/ reimbursement structure
  - 5.6.7.3. Competitive scenario
  - 5.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6.8. Denmark
  - 5.6.8.1. Key country dynamics
  - 5.6.8.2. Regulatory framework/ reimbursement structure
  - 5.6.8.3. Competitive scenario
  - 5.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Asia Pacific
- 5.7.1. Japan
  - 5.7.1.1. Key country dynamics
  - 5.7.1.2. Regulatory framework/ reimbursement structure
  - 5.7.1.3. Competitive scenario
  - 5.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7.2. China
  - 5.7.2.1. Key country dynamics
  - 5.7.2.2. Regulatory framework/ reimbursement structure
  - 5.7.2.3. Competitive scenario
  - 5.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7.3. India
  - 5.7.3.1. Key country dynamics
  - 5.7.3.2. Regulatory framework/ reimbursement structure
  - 5.7.3.3. Competitive scenario
  - 5.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7.4. Australia
  - 5.7.4.1. Key country dynamics
  - 5.7.4.2. Regulatory framework/ reimbursement structure
  - 5.7.4.3. Competitive scenario
  - 5.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7.5. South Korea
  - 5.7.5.1. Key country dynamics
  - 5.7.5.2. Regulatory framework/ reimbursement structure
  - 5.7.5.3. Competitive scenario
  - 5.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7.6. Thailand
  - 5.7.6.1. Key country dynamics
  - 5.7.6.2. Regulatory framework/ reimbursement structure
  - 5.7.6.3. Competitive scenario
  - 5.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
5.8. Latin America
- 5.8.1. Brazil
  - 5.8.1.1. Key country dynamics
  - 5.8.1.2. Regulatory framework/ reimbursement structure
  - 5.8.1.3. Competitive scenario
  - 5.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
- 5.8.2. Mexico
  - 5.8.2.1. Key country dynamics
  - 5.8.2.2. Regulatory framework/ reimbursement structure
  - 5.8.2.3. Competitive scenario
  - 5.8.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
- 5.8.3. Argentina
  - 5.8.3.1. Key country dynamics
  - 5.8.3.2. Regulatory framework/ reimbursement structure
  - 5.8.3.3. Competitive scenario
  - 5.8.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
5.9. MEA
- 5.9.1. South Africa
  - 5.9.1.1. Key country dynamics
  - 5.9.1.2. Regulatory framework/ reimbursement structure
  - 5.9.1.3. Competitive scenario
  - 5.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
- 5.9.2. Saudi Arabia
  - 5.9.2.1. Key country dynamics
  - 5.9.2.2. Regulatory framework/ reimbursement structure
  - 5.9.2.3. Competitive scenario
  - 5.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
- 5.9.3. UAE
  - 5.9.3.1. Key country dynamics
  - 5.9.3.2. Regulatory framework/ reimbursement structure
  - 5.9.3.3. Competitive scenario
  - 5.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
- 5.9.4. Kuwait
  - 5.9.4.1. Key country dynamics
  - 5.9.4.2. Regulatory framework/ reimbursement structure
  - 5.9.4.3. Competitive scenario
  - 5.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
- 6.3.1. List of key distributors and channel partners
- 6.3.2. Key customers
- 6.3.3. Key company market share analysis, 2023
- 6.3.4. Allergan
  - 6.3.4.1. Company overview
  - 6.3.4.2. Financial performance
  - 6.3.4.3. Product benchmarking
  - 6.3.4.4. Strategic initiatives
- 6.3.5. Sanofi
  - 6.3.5.1. Company overview
  - 6.3.5.2. Financial performance
  - 6.3.5.3. Product benchmarking
  - 6.3.5.4. Strategic initiatives
- 6.3.6. Genzyme Corporation
  - 6.3.6.1. Company overview
  - 6.3.6.2. Financial performance
  - 6.3.6.3. Product benchmarking
  - 6.3.6.4. Strategic initiatives
- 6.3.7. Anika Therapeutics, Inc.
  - 6.3.7.1. Company overview
  - 6.3.7.2. Financial performance
  - 6.3.7.3. Product benchmarking
  - 6.3.7.4. Strategic initiatives
- 6.3.8. Salix Pharmaceuticals
  - 6.3.8.1. Company overview
  - 6.3.8.2. Financial performance
  - 6.3.8.3. Product benchmarking
  - 6.3.8.4. Strategic initiatives
- 6.3.9. Seikagaku Corporation
  - 6.3.9.1. Company overview
  - 6.3.9.2. Financial performance
  - 6.3.9.3. Product benchmarking
  - 6.3.9.4. Strategic initiatives
- 6.3.10. F. Hoffmann-La Roche Ag
  - 6.3.10.1. Company overview
  - 6.3.10.2. Financial performance
  - 6.3.10.3. Product benchmarking
  - 6.3.10.4. Strategic initiatives
- 6.3.11. Galderma Laboratories L.P.
  - 6.3.11.1. Company overview
  - 6.3.11.2. Financial performance
  - 6.3.11.3. Product benchmarking
  - 6.3.11.4. Strategic initiatives
- 6.3.12. Zimmer Biomet
  - 6.3.12.1. Company overview
  - 6.3.12.2. Financial performance
  - 6.3.12.3. Product benchmarking
  - 6.3.12.4. Strategic initiatives
- 6.3.13. Smith & Nephew Plc
  - 6.3.13.1. Company overview
  - 6.3.13.2. Financial performance
  - 6.3.13.3. Product benchmarking
  - 6.3.13.4. Strategic initiatives
- 6.3.14. Ferring B.V.
  - 6.3.14.1. Company overview
  - 6.3.14.2. Financial performance
  - 6.3.14.3. Product benchmarking
  - 6.3.14.4. Strategic initiatives
- 6.3.15. Lifecore Biomedical, LLC
  - 6.3.15.1. Company overview
  - 6.3.15.2. Financial performance
  - 6.3.15.3. Product benchmarking
  - 6.3.15.4. Strategic initiatives
- 6.3.16. HTL Biotechnology
  - 6.3.16.1. Company overview
  - 6.3.16.2. Financial performance
  - 6.3.16.3. Product benchmarking
  - 6.3.16.4. Strategic initiatives
- 6.3.17. Shiseido Company, Limited
  - 6.3.17.1. Company overview
  - 6.3.17.2. Financial performance
  - 6.3.17.3. Product benchmarking
  - 6.3.17.4. Strategic initiatives
- 6.3.18. Bloomage Biotechnology Corporation Limited
  - 6.3.18.1. Company overview
  - 6.3.18.2. Financial performance
  - 6.3.18.3. Product benchmarking
  - 6.3.18.4. Strategic initiatives
- 6.3.19. LG Life Sciences Ltd (LG Chem.)
  - 6.3.19.1. Company overview
  - 6.3.19.2. Financial performance
  - 6.3.19.3. Product benchmarking
  - 6.3.19.4. Strategic initiatives
- 6.3.20. Maruha Nichiro, Inc.
  - 6.3.20.1. Company overview
  - 6.3.20.2. Financial performance
  - 6.3.20.3. Product benchmarking
  - 6.3.20.4. Strategic initiatives

简介目录图表

List of Tables

Table 1 List of abbreviation
Table 2 North America Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 3 North America Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 4 U.S. Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 5 Canada Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 6 Europe Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 7 Europe Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 8 Germany Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 9 UK Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 10 France Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 11 Italy Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 12 Spain Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 13 Denmark Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 14 Sweden Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 15 Norway Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 16 Asia Pacific Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 17 Asia Pacific Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 18 China Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 19 Japan Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 20 India Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 21 South Korea Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 22 Australia Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 23 Thailand Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 24 Latin America Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 25 Latin America Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 26 Brazil Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 27 Mexico Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 28 Argentina Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 29 MEA Hyaluronic Acid market, by region, 2018 - 2030 (USD Million)
Table 30 MEA Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 31 South Africa Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 33 UAE Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)
Table 34 Kuwait Hyaluronic Acid market, by application, 2018 - 2030 (USD Million)